12th Apr 2012 16:15
First quarter 2012 results date notification - April 26, 2012
Dublin, Ireland - April 12, 2012 - Shire plc , the global specialty biopharmaceutical company, will announce first quarter 2012 earnings on Thursday April 26, 2012.
Results press release will be 12:00 BST / 07:00 EDT
issued at:
Investor conference call time: 14:00 BST / 09:00 EDT
Live conference call for investors:
Angus Russell, Chief Executive Officer and Graham Hetherington, Chief FinancialOfficer will host the investor and analyst conference call at 14:00 BST/9:00EDT.
The details of the conference call are as follows:
UK dial in: 0800 077 8492 or 0844 335 0351 US dial in: 1 866 8048688 or 1 718 3541175
International dial in: +44 844 335 0351 Global Access Numbers: http://www.btconferencing.com/globalaccess/?bid=54_attended
Password/Conf ID: 338 270 Live Webcast: http://www.shire.com/shireplc/en/investors Replay:A replay of the presentation will be available for two weeks by phone and bywebcast for one year. Details can be found on our Investor Relations website http://www.shire.com/shireplc/en/investors.
For further information please contact:
Investor Relations Souheil Salah [email protected] +44 1256 894 160 Erin K. Kelly [email protected] +1 781 482 9541 Notes to editorsSHIRE PLC
Shire's strategic goal is to become the leading specialty biopharmaceuticalcompany that focuses on meeting the needs of the specialist physician. Shirefocuses its business on attention deficit hyperactivity disorder, human genetictherapies, gastrointestinal diseases and regenerative medicine as well asopportunities in other therapeutic areas to the extent they arise throughacquisitions. Shire's in-licensing, merger and acquisition efforts are focusedon products in specialist markets with strong intellectual property protectionand global rights. Shire believes that a carefully selected and balancedportfolio of products with strategically aligned and relatively small-scalesales forces will deliver strong results.For further information on Shire, please visit the Company's website: www.shire.com. Registered in Jersey, No. 99854, 22 Grenville Street, St Helier, Jersey JE4 8PXPress Release www.shire.com
XLONRelated Shares:
Shire